Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Gilead Sciences Inc
GILD
Healthcare
Biotechnology
Gilead Sciences, Inc. is a biopharmaceutical company. It is engaged in advancing medicines to prevent and treat life-threatening diseases, including human immunodeficiency virus (HIV), viral hepatitis, coronavirus disease 2019 (COVID-19) and cancer. It is focused on the discovery, development and commercialization of medicines in areas of unmet medical need. Its portfolio of marketed products...
includes AmBisome, Atripla, Biktarvy, Cayston, Complera, Descovy, Descovy for PrEP, Emtriva, Epclusa, Eviplera, Genvoya, Harvoni, Hepcludex, Hepsera, Jyseleca, Letairis, Odefsey, Sovaldi, Stribild, Sunlenca, Tecartus, Trodelvy, Truvada, Truvada for PrEP, Tybost, Veklury, Vemlidy, Viread, Vosevi, Yescarta and Zydelig. Its product candidates include Bulevirtide, Lenacapavir, Axicabtagene ciloleucel, and Domvanalimab and zimberelimab, and seladelpar. Seladelpar shall be used for the treatment of primary biliary cholangitis (PBC), including pruritus. The Company operates in more than 35 countries.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:GILD)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
Next
(1)
•••
Rebecca
X
Post by
Rebecca
on Apr 26, 2022 1:18am
"Julia Levy Award" Recipient David Allan and Dr. John McGraw
(1)
•••
Rebecca
X
Post by
Rebecca
on Apr 19, 2022 1:05am
FSD Pharma Inc: Lucid MS Video
FSD Pharma is delighted to announce pre-clinical findings
...more
(2)
•••
zeropointenergy
X
Post by
zeropointenergy
on Oct 09, 2021 6:41am
IVERMICTIN KILLS COVID 19 !
NICE China Reports Zero New Locally Acquired Covid-19 Cases for Fourth Day in a Row
(2)
•••
zeropointenergy
X
Post by
zeropointenergy
on Oct 06, 2021 7:39am
ONE DRUG PILL WIPES OUT COVID 19!
India's Ivermectin Blackout - Part V: The Secret Revealed ... Sep 27, 2021 · By September 12, 2021, Livemint reported that 34 districts were declared COVID-free
...more
(18)
•••
omylord
X
Post by
omylord
on Jun 09, 2021 4:04pm
TRODELUY
This new drug , vaccine ive been reading about may help my wife , stage 2 triple negative breast cancer . anyone have any contacts , maybe hope .
(0)
•••
Saaaa1
X
Post by
Saaaa1
on May 06, 2021 9:00pm
$iMIN making moves in Ethereum Crypto !! 🚀🚀🚀🚀🚀
iMining Launches Fractional Staking to Enable Retail Investors to Participate in Ethereum 2.0's Proof-Of-Stake Mining Vancouver, British Columbia - (Newsfile Corp. - April 20, 2021) - iMining
...more
(2)
•••
Jilly17
X
Comment by
Jilly17
on Apr 13, 2021 6:31pm
RE:Sky’s the limit
I bought in many,v many moons ago. Looks like it might finally pay off!
(838)
•••
Gabriel
X
Post by
Gabriel
on Apr 09, 2021 4:26pm
Cantor Fitzgerald analysis on CNBC
I took a video. https://www.dropbox.com/s/ntbt7kuog3xvh80/IMG_8644.MOV?dl=0
(173)
•••
goodheart-r
X
Post by
goodheart-r
on Jan 25, 2021 1:14pm
looking to partner with big pharma-wow-
9:33NOW PLAYING
(3)
•••
Mil_Man54
X
Post by
Mil_Man54
on Dec 26, 2020 8:20am
Bonvoyage12.....Lying Pumper
Ignore this clown as he posts lies trying to mislead investors about the actual state of the company...he also posts this same BS on multiple boards
(3)
•••
cool888
X
Post by
cool888
on Nov 20, 2020 7:38am
W.H.O. Rejects Antiviral Drug Remdesivir
https://www.nytimes.com/2020/11/19/health/remdesivir-covid-19.html
(5)
•••
SmallCapPaul
X
Post by
SmallCapPaul
on Oct 06, 2020 1:11pm
COVID Vaccine Timing & Politics
https://www.channelchek.com/news-channel/The_Timing_of_a_COVID_Vaccine
(0)
•••
tanoa13
X
Post by
tanoa13
on Aug 19, 2020 1:35am
Sky’s the limit
Just got it . Hope this stock skyrockets . Also, has anyone heard of novabay pharmaceuticals? Heard about it in passing but not sure . Glta
(0)
•••
Nonyah
X
Post by
Nonyah
on Aug 09, 2020 10:31am
Better Development Tools for a New Golden Era of Psychopharm
Better Development Tools for a New Golden Era of Psychopharmacology https://www.thecannabisinvestor.ca/better-development-tools-for-a-new-golden-era-of-psychopharmacology/
(24)
•••
Higherhopes2020
X
Post by
Higherhopes2020
on Aug 05, 2020 11:18am
Revive Therapeutics U.S. FDA Approval phase 3 trial covid19
evive Therapeutics U.S. FDA Approval phase 3 trial covid19 Revive Therapeutics Ltd. (RVVTF) Other OTC - Other OTC Delayed Price.
...more
Prev
1
2
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Tribe Announces Preliminary Q4-2024 Results, Achieving Positive Adjusted EBITDA and Increased Revenue Run-Rate
Creating a Non-Opioid Solution for Chronic Pain Management